AI-Based Strategies for Predicting Glaucoma Progression

Risk factor identification aims to guide timely surgical intervention.

Big data and artificial intelligence (AI) hold strong potential for improving glaucoma patient management by enabling individualised assessment and prediction of disease progression. However, validating these AI-based prognostic approaches will be essential before they are ready for clinical implementation...

Author: Cheryl Guttman Krader

Slightly More than MIGS

A host of promising options are on the horizon for the procedure.

Minimally invasive glaucoma surgery (MIGS) is a relatively new therapeutic category that has dramatically expanded since the term was first introduced in 2009, providing surgeons with an amazing set of tools. A look at the investigational pipeline reveals there is much more to look forward to...

Author: Cheryl Guttman Krader

PMLT: A New Frontier for Ocular Hypertension

A new laser procedure with the potential to complement or surpass SLT.

For the first time, Pattern MicroSecond Laser Trabeculoplasty (PMLT) has been performed in Europe. Davide Borroni MD of the University of Riga performed the procedure. An evolution of Micropulse Laser Trabeculoplasty (MLT)...

Author: Timothy Norris

Debating the Future of Glaucoma Surgery

Challenges and opportunities await cataract surgeons interested in integrating early glaucoma treatment as part of comprehensive care.

As cataract surgeons increasingly take on glaucoma procedures, the divide between the two fields is blurring...

Author: Sean Henahan

Glaucoma Treatment in a War Zone

War in Ukraine has forced the country’s doctors to improvise and overcome remarkable challenges.

Four years after Russia’s full-scale invasion of Ukraine, the conflict there continues to make headlines. Hundreds of thousands of people have been killed and millions more displaced, and the world has seen it all unfold in real time.

Author: Andrew Sweeney

Meeting Challenges Through Innovation

Innovators Den finalists pitch solutions to knotty ophthalmic problems.

With populations ageing worldwide, dislocated and subluxated IOLs are becoming more common, particularly in post-trauma cases or after complicated cataract surgeries.

Author: Howard Larkin

The Future of Glaucoma Medication

Towards a clearer, more efficient way to address outflow.

In glaucoma treatment, the sheer number of different compounds, variations, and brands on the market can become a little bit confusing. However, the future of glaucoma medication promises to be brighter...

Author: Timothy Norris

A Challenging Case of Aqueous Misdirection

An unusual solution to an unusual problem.

“In glaucoma surgery, we don’t really like postoperative surprises,” said Andrew Tatham MD, as he presented a challenging case of aqueous misdirection...

Author: Timothy Norris

Supplement: ESCRS Clinical Trends Series: Glaucoma

In this edition of the ESCRS Clinical Trends Series, ESCRS President, Prof. Burkhard Bick examines key findings from the 2025 ESCRS Clinical Trends Survey, providing an in-depth analysis of how society members approach glaucoma management - from diagnosis to treatment - with a particular emphasis on minimally invasive glaucoma surgery (MIGS).

Is AI a Future Frenemy?

The technology presents challenges and benefits for ophthalmologists.

Artificial intelligence is becoming increasingly precise, offering ophthalmologists powerful tools for diagnosis and imaging. However, to maintain the best quality of care, some boundaries need to be established...

Author: Timothy Norris